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Abstract
The diagnosis of primary headache disorders is clinical and based on the diagnostic criteria of the International Headache
Society (ICHD-3-beta). However several brain conditions may mimic primary headache disorders and laboratory
investigation may be needed. This necessity occurs when the treating physician doubts for the primary origin of
headache. Features that represent a warning for a possible underlying disorder causing the headache are new
onset headache, change in previously stable headache pattern, headache that abruptly reaches the peak level,
headache that changes with posture, headache awakening the patient, or precipitated by physical activity or Valsalva
manoeuvre, first onset of headache ≥50 years of age, neurological symptoms or signs, trauma, fever, seizures, history of
malignancy, history of HIV or active infections, and prior history of stroke or intracranial bleeding. All national headache
societies and the European Headache Alliance invited to review and comment the consensus before the final
draft. The consensus recommends brain MRI for the case of migraine with aura that persists on one side or in
brainstem aura. Persistent aura without infarction and migrainous infarction require brain MRI, MRA and MRV.
Brain MRI with detailed study of the pituitary area and cavernous sinus, is recommended for all TACs. For primary
cough headache, exercise headache, headache associated with sexual activity, thunderclap headache and hypnic
headache apart from brain MRI additional tests may be required. Because there is little and no good evidence the
committee constructed a consensus based on the opinion of experts, and should be treated as imperfect.
Keywords: Primary headache disorders, Migraine, Tension-type headache, TACs, Consensus, Diagnostic tests,
Brain MRI
Main text
Headache is a symptom in the main rather a condition.
Only when headache attacks fulfill specific diagnostic
criteria consistently does a primary headache disorder
occur [1]. Accompanying symptoms are important to-
gether with the particular headache characteristics in-
cluding pain severity, duration, quality and location. In
most cases headache is primary but secondary headache
disorders may be related to life threatening conditions.
They may respond to common analgesics and mimic
primary ones a lot. Diagnostic tests are necessary there-
fore when the treating physician doubts for the primary
origin of headache. Up-to-date there is no official
recommendation for these tests, although headache re-
mains the commonest presenting symptom in people ask-
ing medical consultation. To bridge this gap European
Headache Federation (EHF) appointed an internal and
external committee to prepare a consensus on the diag-
nostic testing that primary headache disorders may re-
quire. The procedure followed was consisted of three
phases. In phase one members of the Executive Board of
EHF (internal committee: DDM, AS, CL, KP, VO and PM)
prepared the first draft that was send to all National
European Headache Societies for review. Thirteen Na-
tional Headache Societies replied (40 %) with comments.
European Headache Alliance also participated in this re-
view phase. Based on their comments and suggestions
draft 2 was edited (phase 2) that was applied for review in
a group of distinguished headache specialists that EHF
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appointed as the external subcommittee (MA, HCD,
MDF, PJG, JP, and JO). After fulfilling all comments into
one manuscript the final draft of the consensus was ar-
ranged (phase 3), which is presented in the Appendix.
Table 1 summarizes the principles.
Appendix
1. Introduction
The following recommendations concern adults with
headache as the leading symptom over the age of 18.
The majority of patients presenting with headache suf-
fer from primary headache disorders. The diagnosis of
primary headache disorders is mainly clinical and based
on both history taking and a normal clinical neurological
examination. However, medical practice changes with
time, and laboratory investigation may be needed to ex-
clude even very rare conditions in order to protect better
patients and improve headache management. Investiga-
tions are required when the treating physician is in
doubt whether they are dealing with a primary headache
disorder. Clinical features that warn of a possible under-
lying disorder causing headache include:
1. Headache that peaks in severity in less than five
minutes
2. New headache type versus a worsening of a
previous headache
3. Change in previously stable headache pattern
4. Headache that changes with posture (e.g. standing up)
5. Headache awakening the patient
6. Headache precipitated by physical activity or Valsalva
manoeuvre (e.g. coughing, laughing, straining)
7. First onset ≥50 years of age




12. History of malignancy
13. History of HIV or active infections
Physicians should also consider that identification of a
comorbid disorder does not necessarily imply that the
headache can be attributed to the condition. A secondary
headache disorder can be diagnosed when one of the
following features is present [1]:
1. Another disorder documented to be able to cause
headache has been diagnosed or is suspected.
2. Headache has developed in close temporal relation
to the onset of the presumed causative disorder.
3. Headache has significantly worsened in parallel
with worsening of the presumed causative disorder
and/or headache has significantly improved in
parallel with improvement of the presumed causative
disorder.
4. Headache has characteristics typical of the causative
disorder and other evidence exists of causation.
5. Headache fulfills criteria for primary headache, but
has a markedly late onset.
Additionally, for those patients who present with a his-
tory of headache attacks with unchanged features and
have not been investigated previously, the following rec-
ommendations are appropriate. When the diagnosis of a
primary headache has been made for years, but head-
ache features change or additional general symptoms
occur or neurological examination changes, apart from
brain MRI additional investigation may be required ac-
cording to the treating physicians’ decision and the pa-
tient’s specific clinical presentation. If a patient asks for
laboratory evaluation outside the above or the following
recommendations, or the treating physician feels that
there is need for such an evaluation, the committee rec-
ommends dealing with such situations on a case by case
basis and being aware of cost issues. Local reimburse-
ment regulations should be considered as well.
The following recommendations are based on the
opinion of experts, and should be treated as imperfect.
The recommendations are supported by a literature
search done for each specific primary headache disorder
covering articles published the last 10 years.
2. Recommendations
The following recommendations cover the first onset of
a primary headache disorder. Recommendations follow
the classification of the International Classification of
Headache Disorders (ICHD-3-beta) [1].
1. Migraine
1.1 Migraine without aura
Generally no investigation is required, in particular when
no preventive treatment is needed. For episodic migraine
without aura that needs preventive treatment, some ex-
perts recommend brain MRI when three first line prevent-
ive treatments fail [2, 3]. In the presence of a normal
neurological examination this may not be necessary. Add-
itionally, carotid ultrasound or MRA of the carotid and
vertebral arteries with fat saturated T1 sequences are rec-
ommended by some experts when migraine occurs in pa-
tients over 50 years of age for the first time, or in the
presence of cerebrovascular comorbidity [4]. Again in the
absence of non-headache disorder neurological symptoms
or signs, this is not a universal practice. In the appropriate
clinical setting, a physician should consider giant cell ar-
teritis, with symptoms such as pain upon mastication, vis-
ual disturbance, suspect temporal artery upon palpation,
and perform recommended testing.
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1.1 Migraine without aura None
Frequent episodic migraine Brain MRIa
Carodit ultrasound or MRAa
ESRa
1.2 Migraine with aura Brain MRIa
1.2.2 Migraine with brainstem aura Brain MRI & MRA
EEGa
Carotid and vertebral arteries ultrasound/or CT or MRAa
Genetic evaluationa




1.4 Complications of migraine Brain MRI
1.4.1/2 Persistence of aura symptoms Emergency brain CT or MRI
Carotid and vertebral arteries ultrasound/or CT or MRA
ESRa
1.4.3 Migrainous infarction Emergency brain CT or MRI
Carotid and vertebral arteries ultrasound/or CT or MRAa
ESRa
1.4.3 Migraine aura-triggered seizures Repetitive EEGs or video EEG
1.5 Probable migraine Brain MRIa




2.1 Infrequent TTH None




3 TACs (all) Brain MRI
Brain MRA and Carotid and vertebral arteries ultrasound/or CT or MRAa
Pituitary function testinga
3.1 Cluster headache +Polysomnographya
3.2 Paraxysmal Hemicrania Brain MRI and MRA and Carotid and vertebral arteries ultrasound/or CT or
MRAa
3.3 Suna & Sunct + High resolution MRI of brainstem
3.4 Hemicrania Continua Brain MRI
Brain MRA and Carotid and vertebral arteries ultrasound/or CT or MRAa
4 Other primary headache disorders
4.1 Primary cough headache Brain MRI
Cranio-cervical and brain MRAa
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1.2 Migraine with aura
Brain MRI is suggested for almost all migraine with aura
sub-forms based solely on their rarity and concern with
accurate diagnosis. For migraine typical aura, unless
there are other reasons, investigation is not recom-
mended however. In migraine with brainstem aura some
experts would recommend brain MRA. If brain MRI or
MRA shows abnormalities the treating physician will de-
cide whether additional investigation is required to rule
out potentially related vascular (AV malformations, ca-
rotid dissection) or in some cases, heart conditions, such
as patent foramen ovale (PFO), may be considered al-
though there are no compelling data to treat PFO for
the indication of migraine. Unless epilepsy is being con-
sidered, EEG has no place in the evaluation of primary
headache disorders. Occipital seizures are noted to
produce visual disturbance that is phenotypically dis-
tinct from migraine [5, 6]. Prolonged video EEG is
never useful to investigate migraine aura, unless the
clinician is considering epilepsy as a diagnosis. Transi-
ent ischemic attacks should be ruled out, when the on-
set of symptoms is abrupt, symptoms are exclusively
negative (e.g. hemianopsia) or the aura is prolonged or
very short in duration [1]. Angio-CT or MRA of carotid
and vertebral arteries with fat saturated T1 sequences is
recommended by some experts when migraine aura
occurs for the first time in patients over 50 years of age, or
in the presence of cerebro-vascular comorbidity [4], al-
though when aura typical a case can be made not to inves-
tigate. For hemiplegic migraine, mutation screening of
CACNA1A (FHM1), ATP1A2 (FHM2) and SCN1A
(FHM3) is suggested although it has neither phenotypic
nor therapeutic application at this time [7].
1.3 Chronic migraine
When there is the typical history of gradual increase of
headache frequency over the years and ICHD-3-beta cri-
teria for chronic migraine are satisfied, there is no need
for additional investigations. Funduscopy should be a
routine part of the evaluation of all newly presenting pa-
tients with a headache disorders and clinicians should be
particularly mindful of its importance in patients who
are over-weight. MR venography of the brain is recom-
mended in the presence of symptoms suggestive of
intracranial hypertension, such as pulsatile tinnitus and
transient visual obscurations, or increasing pain with
Table 1 Tests recommended for primary headache disorders (Continued)
4.2 Primary exercise headache Brain MRI and MRA/MRV
Lumbar puncturea
Carotid & vertebral ultrasound, or CT or MRA
Cardiological evaluation a
4.3 Primary headache associated with sexual activity Brain MRI, MRA/MRV
Carotid and vertebral arteries ultrasound/or CT or MRA
Lumbar puncturea
ESR, CRPa
4.4 Primary thunderclap headache Brain MRI, MRA/MRV
Carotid and vertebral arteries ultrasound/or CT or MRA
Lumbar puncturea
ESR, CRPa
4.5 Cold-stimulus headache None
4.6 External-pressure headache None
4.7 Primary stabbing headache Brain MRI, MRA/MRV
Carotid and vertebral arteries ultrasound/or CT or MRA
Lumbar puncturea
ESR, CRPa
4.8 Nummular headache Brain MRI, ESR, ANF and RF
4.9 Hypnic headache Brain MRI, ESR, CRP
Polysomnography
24-hour blood pressure monitoring
4.10 New daily persistent headache Brain MRI, MRA
Lumbar puncturea
aIndicates specific conditions
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Valsalva maneuver or daily morning headache that spon-
taneously resolves during the day [8]. Lumbar puncture
with CSF manometry, to look for idiopathic intracranial
hypertension (IIH) without papilledema, is not recom-
mended, unless clinical signs indicate IIH [9]. In all
chronic migraine patients when intracranial hyperten-
sion is established, or suspected, metabolic, toxic and
endocrine disorders need to be considered by appropri-
ate tests. Polysomnography may be recommended in the
presence of signs and symptoms (e.g. strictly morning
headache) suggestive of obstructive sleep apnea (OAS),
although there is data indicating that migraine is not re-
lated to OAS in the general population [10]. Detecting
comorbid psychiatric disorders is appropriate in all
patients.
1.4 Complications of migraine
In the presence of persistence of aura symptoms the ad-
mission to the emergency room and urgent brain DWI
MRI is recommended to exclude the presence of brain
ischaemia. Generally, persistent aura without infarction
and migrainous infarction require both brain MRI, MRA
and MRV, plus further investigation for thrombophilia
and other risk factors for brain thrombosis, including
patent PFO, although the causative relation of PFO and
migraine is questionable [11] (not all experts agree there
is enough data to support testing for PFO). For migraine
aura-triggered seizures, repetitive EEGs or long lasting
video-EEG recording is recommended [5, 6].
1.5 Probable Migraine with aura
For probable migraine with aura, the same investigations
such as those in section1.2 Migraine with aura are
recommended.
1.6 Episodic syndromes that may be associated with
migraine
For episodic syndromes that may be associated with mi-
graine, extensive gastrointestinal work-up is recommended.
For benign paroxysmal vertigo and torticollis brain MRI
may be needed, according to treating physician’s opinion.
2. Tension-type headache
2.1 Infrequent TTH
No investigation is needed.
2.2 Frequent TTH and 2.3 Chronic TTH
MRI brain may be useful when three first line preventive
treatments fail [12]. For overweight or obese individuals
paraclinical investigation as in 1.3 (Chronic migraine).
2.4 Probable TTH
Infrequent probable TTH as 2.1; frequent and chronic
probable TTH, as 2.2.
3. Trigeminal autonomic cephalalgias (TACs)
Brain MRI with detailed study of the pituitary area and
cavernous sinus, is recommended for all TACs. When
three consecutive preventive treatments fail additional
MRA brain and carotid/vertebral arteries may be re-
quired and in the presence of a (partial) Horner’s syn-
drome, additional imaging of the apex of the lung may
be warranted, especially in smokers [13]. Pituitary func-
tion testing should be considered in refractory TAC pa-
tients in addition [14]. Comorbidity with trigeminal
neuralgia (TAC-tic syndrome) should be ruled out in
cases of refractory TACs.
3.1 Cluster headache
The same exams as in section 3. In addition polysomno-
graphy may be needed when patients are snoring and pi-
tuitary function testing should be considered in refractory
cluster headache (CH) patients [15, 16]. Restless legs syn-
drome may also be co-exist with cluster headache, but this
does not seem to affect CH management [17]. During
polysomnography restless legs syndrome could be docu-
mented and treated appropriately. Despite the above rec-
ommendations, CH patients with long history of CH
bouts separated by asymptomatic periods that respond to
preventive treatment may not need neuroimaging.
3.2 Paroxysmal hemicrania
The same exams as in section 3.
3.3 SUNCT (Short-lasting unilateral neuralgiform headache
attacks with conjunctival injection and tearing) and SUNA
A SUNCT syndrome may be hard to differentiate from V1
trigeminal neuralgia. Evidence for neurovascular compres-
sion can be sought by high-resolution MRI sequences of
the brain stem and cranial nerves [18], although if clini-
cians are unsure about the diagnosis it is preferable to in-
volve expert colleagues before obtaining a neurosurgical
opinion. SUNCT has also been described in multiple
sclerosis [19, 20].
3.4 Hemicrania continua
Patients with secondary, or symptomatic hemicrania
continua (HC) may also respond to indomethacin. The
HC phenotype can be observed in association with dif-
ferent brain diseases, in both cervical and intracranial
blood vessels abnormalities, and even in lung cancer
[21]. In selected patients evaluation for cervicogenic
headache may be warranted.
4. Other primary headache disorders
A case can be made for MRI brain in all headache disor-
ders of this section, although some with less vigor, such
as typical Primary Stabbing Headache.
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4.1 Primary cough headache
Cranio-cervical and brain MRI, to exclude structural ab-
normalities, such as a Chiari 1 malformation, subtentorial
tumors [1] or intermittend hydrocephalus, is recom-
mended when headache attacks persist. This type of head-
ache is rarely secondary to cervical or intracranial vascular
pathology. MRA of brain may be helpful but MRA of the
cervical arteries is not generally recommended [22]. In
cough headache with tonsilar descent a dynamic MRI CSF
study and/or MRI gandolinium can be necessary. MRI
CSF flow measurement could be useful when low or high
intracranial pressure is suspected.
4.2 Primary exercise headache
In addition to brain MRI, lumbar puncture, brain MRA
and MRA of carotid/vertebral arteries are also recom-
mended to rule out subarachnoid hemorrhage and arterial
dissection on first occurrence of exercise headache, as-
suming time to peak severity of headache is short, i.e. in
minutes. Notably, the sensitivity of brain CT for subarach-
noid hemorrhage approaches almost 100 % within the first
hours, while the sensitivity of lumbar puncture with detec-
tion of bilirubin and MRI with hemosiderin sensitive
sequences increases with time [23]. With recurrent exer-
cise headaches these examinations should be made when
warning signs occur as described in the introduction.
Cardiological evaluation is recommended to exclude
coronary heart disease resulting in cardiac cephalalgia.
Pheochromocytoma, carcinoid, intracranial hypertension,
spontaneous intracranial hypotension and cerebral venous
thrombosis should be ruled out with appropriate add-
itional investigation upon the treating physician’s decision
[24]. Reversible vasospasm and/or arterial hypertension
can be a diagnostic challenge as well.
4.3 Primary headache associated with sexual activity
To exclude subarachnoid hemorrhage and arterial dissec-
tion in addition to brain MRI, brain MRA-venography
and ultrasound/or MRA of carotid and vertebral arteries
are recommended to rule out RCVs. In younger subjects,
additional test of D-dimer may be useful. Upon physician’s
decision a lumbar puncture and CSF bilirubin test is also
considered, depending on the time of evaluation, after the
episode of headache [23]. Blood tests including an
erythrocyte sedimentation rate (ESR) and a CRP may be
useful as well. Appropriate test to rule out reversible vaso-
spasm and/or arterial hypertension may be needed.
4.4 Primary thunderclap headache
The same exams as in section 4.3
4.5 Cold-stimulus headache
No investigation is needed.
4.6 External-pressure headache
No investigation is needed.
4.7 Primary stabbing headache
Some experts would advocate exams as in section 4.3 in
this cohort, while others would contend this disorder, in
the presence of a normal clinical examination, is so typical,
investigation may not be necessary.
4.8 Nummular headache
Apart from brain MRI, ESR, ANF and RF may be
useful [25].
4.9 Hypnic headache
MRI of the brain, blood testing (including ESR, WBC
and CRP), polysomnography and 24-hour blood pressure
monitoring are recommended in all patients [26, 27].
4.10 New daily persistent headache
A gadolinium-enhanced brain MRI with MR venography
and a lumbar puncture with CSF manometry can be in-
dicated in selected patients. Viral titers for Epstein Barr
virus and cytomegalovirus may be helpful, upon treating
physicians’ appraisal [28].
3. Notes
3.1 Gadolinium – enhanced MRI in some cases is
recommended to exclude blood-brain barrier damage
and leptomeningeal enhancement (e.g. low CSF pressure
headache).
3.2 In the presence of symptoms suggestive of intra-
cranial hypertension or to follow-up intracranial hyper-
tension optical coherence tomography (OCT) of the
retina may be useful [29, 30].
3.3 A person is considered over weighted when the body
mass index (BMI) is higher than 25.0 and obese when
BMI > 30 [http://www.cdc.gov/obesity/adult/defining.html].
3.4 Arterial dissection does not only mimic migraine
but also TACs in particular [31], thus caution to exclude
this condition is suggested.
3.5 Indomethacin-responsiveness has been described
in secondary, or symptomatic paroxysmal hemicrania,
thus pseudo-positive indomethacin test should be con-
sidered [32].
4. Comments
4.1 European Federation of Neurological Societies pub-
lished guidelines for neuroimaging procedures in 2011.
It is stated, “(i) Interictal EEG is not routinely indicated
in the diagnostic evaluation of patients with headache.
Interictal EEG is, however, indicated if the clinical his-
tory suggests a possible diagnosis of epilepsy (differen-
tial diagnosis). Ictal EEG could be useful in certain
patients suffering from hemiplegic or basilar migraine.
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(ii) Recording evoked potentials is not recommended
for the diagnosis of headache disorders. (iii) There is no
evidence warranting recommendation of reflex re-
sponses or autonomic tests for the routine clinical
examination of patients with headache. (iv) Manual pal-
pation of pericranial muscles, with standardized palpa-
tion pressure, can be recommended for subdividing
patient groups but not for diagnosis. Pain threshold
measurements and EMG are not recommended as clin-
ical diagnostic tests. (v) In adult and pediatric patients
with migraine, with no recent change in attack pattern,
no history of seizures, and no other focal neurological
symptoms or signs, the routine use of neuroimaging is
not warranted. In patients with trigeminal autonomic
cephalalgia, neuroimaging should be carefully consid-
ered and may necessitate additional scanning of intra-
cranial/cervical vasculature and/or the sellar/orbital/
(para) nasal region. In patients with atypical headache
patterns, a history of seizures and/or focal neurological
symptoms or signs, MRI may be indicated. (vi) If at-
tacks can be fully accounted for by the standard head-
ache classification (IHS), a PET or SPECT scan will
normally be of no further diagnostic value. Nuclear
medical examinations of the cerebral circulation and
metabolism can be carried out in subgroups of patients
with headache for the diagnosis and evaluation of com-
plications, when patients experience unusually severe
attacks or when the quality or severity of attacks has
changed. (vii) Transcranial Doppler examination is not
helpful in headache diagnosis” [33]. These recommen-
dations are in line with those presented here. Nuclear
medical examinations this committee believes offer lit-
tle benefit however.
4.2 In an emergency setting only CT scans are available
commonly in several European countries. In this case, CT
scan and CT angiography may replace MRI and MRA.
This applies in particular for the cases of complications of
migraine, primary exercise headache, primary thunderclap
headache, or headache associated with sexual activity.
4.3 History of drug intake is highly recommended, to
exclude or diagnose coexisting medication overuse head-
ache (MOH) in all patients with chronic headache
syndromes.
4.5 In general, if a headache is probable or atypical ac-
cording to ICHD-3-b the threshold for additional inves-
tigations should be lower.
4.6 Psychiatric consultation and potential neuropsycho-
logical testing is recommended by some experts for
almost all cases of any chronic headache disorder. Others
would argue that only those patients with evident co-
morbid psychiatric disorders need referral.
4.7 In patients with anxiety disorder and fear of a
brain tumor, CT might be indicated for psychological
reasons.
4.8 Detailed neurological examination may reveal soft
neurological sings in primary headache disorders but
the relevance of these sings should to be further inves-
tigated [34].
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